One Cannabis Stock Price Prediction Every Investor Needs to See

The cannabis legalization trend is picking up steam now that Canada has fully legalized marijuana. And we've got a cannabis stock price prediction you can't afford to miss as cannabis goes mainstream.

The marijuana industry is expected to skyrocket from $10 billion in legal sales in 2017 to $24.5 billion by 2021.

cannabis stock price predictionThat's a 145% sales increase in just four years, and investing in the right pot stocks now could provide life-changing returns.

But we understand that some investors are still hesitant to place their hard-earned money in pot stocks...

All cannabis use may be legal for our neighbors in Canada, but it's still illegal under U.S. federal law.

SESSIONS OUT: Trump's anti-marijuana AG is history, and the potential path to massive pot stock profits is wide open. Click here to learn about three of the best...

However, we've uncovered a medical marijuana stock that allows risk-averse investors to get in on the $10 billion cannabis market right now.

This biopharmaceutical company has been in business since 1998, and it has the first FDA-approved drug derived from cannabis that could be sold before the end of 2018.

This is the perfect opportunity to profit from the marijuana industry before it becomes completely mainstream...

This Medical Cannabis Stock Could Provide Double-Digit Returns

[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]

UK-based pharmaceutical manufacturer GW Pharmaceuticals Plc. (NASDAQ: GWPH) targets the development of marijuana-based experimental drugs for specific conditions.

GW's Epidiolex drug is focused on treatment for two rare forms of epilepsy. Researchers at GW are currently investigating its use for two other conditions that cause seizures.

In late June 2018, the U.S. Food and Drug Administration (FDA) approved Epidiolex for patients with Dravet Syndrome and Lennox-Gastaut Syndrome. The approval was the first time the FDA had approved a drug that used a cannabis-derived substance.

Money Morning Defense and Tech Specialist Michael A. Robinson forecasts that Epidiolex could generate revenue of up to $1.7 billion by 2026.

This morning (Nov. 9), the GWPH stock price opened at $146.50 per share. One analyst on FactSet believes in the next 12 months GWPH will trade for $227 per share, which is a potential 54.94% profit from today's price.

How You Can Join "the Perfect Pot Stock Portfolio"

Utah and Missouri just legalized medical marijuana.

And Michigan just became the 10th state to open the recreational floodgates.

Pot stocks are already handing investors extraordinary gains. It might be the most profitable sector in the world right now.

And this portfolio is your ticket to become a part of the action.

Every single stock is in the black.

Click here to learn more.

Follow Money Morning on FacebookTwitter, and LinkedIn.